MUTATION OF THE SERINE 15 PHOSPHORYLATION SITE OF HUMAN P53 REDUCES THE ABILITY OF P53 TO INHIBIT CELL-CYCLE PROGRESSION

Citation
M. Fiscella et al., MUTATION OF THE SERINE 15 PHOSPHORYLATION SITE OF HUMAN P53 REDUCES THE ABILITY OF P53 TO INHIBIT CELL-CYCLE PROGRESSION, Oncogene, 8(6), 1993, pp. 1519-1528
Citations number
59
Categorie Soggetti
Genetics & Heredity",Oncology
Journal title
ISSN journal
09509232
Volume
8
Issue
6
Year of publication
1993
Pages
1519 - 1528
Database
ISI
SICI code
0950-9232(1993)8:6<1519:MOTS1P>2.0.ZU;2-5
Abstract
Overexpression of wild-type p53 prevents cells from entering the S pha se of the cell cycle. The amino-terminal transactivation region of p53 is phosphorylated by several protein kinases, including DNA-PK, a nuc lear serine/threonine protein kinase that in vitro requires DNA for ac tivity. DNA-PK was recently shown to phosphorylate serines 15 and 37 o f human p53 (Lees-Miller et al, 1992. Mol. Cell. Biol., 12, 5041-5049) . To prevent phosphorylation at these sites, mutants were constructed that changed the codons for serine 15 or serine 37 to alanine codons. Expression of p53-Ala-37 in stably transformed T98G cells blocked prog ression of the cells into S phase as well as did the expression of wil d-type p53. In contrast, p53-Ala-15 was partially defective in blockin g cell cycle progression. Several cell clones transformed with the mut ant p53-Ala-15 gene expressed normal levels of p53 mRNA but accumulate d little or no detectable p53 protein. However, by using a transient e xpression system driven by a strong cytomegalovirus promoter, we showe d that the inability of p53-Ala-15 to fully block cell cycle progressi on was not due to inadequate levels of expression or to a failure of t he mutant protein to accumulate in the nucleus. These results suggest that phosphorylation of Ser-15 may affect p53 function.